Kymera Therapeutics (KYMR) Asset Utilization Ratio (2020 - 2025)
Historic Asset Utilization Ratio for Kymera Therapeutics (KYMR) over the last 6 years, with Q3 2025 value amounting to 0.0.
- Kymera Therapeutics' Asset Utilization Ratio fell 10022.65% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 10022.65%. This contributed to the annual value of 0.0 for FY2024, which is 9700.73% down from last year.
- According to the latest figures from Q3 2025, Kymera Therapeutics' Asset Utilization Ratio is 0.0, which was down 10022.65% from 0.0 recorded in Q2 2025.
- In the past 5 years, Kymera Therapeutics' Asset Utilization Ratio ranged from a high of 0.14 in Q2 2021 and a low of 0.0 during Q3 2025
- In the last 5 years, Kymera Therapeutics' Asset Utilization Ratio had a median value of 0.09 in 2024 and averaged 0.08.
- In the last 5 years, Kymera Therapeutics' Asset Utilization Ratio soared by 8471.97% in 2023 and then crashed by 10022.65% in 2025.
- Quarter analysis of 5 years shows Kymera Therapeutics' Asset Utilization Ratio stood at 0.12 in 2021, then tumbled by 35.36% to 0.08 in 2022, then surged by 84.72% to 0.14 in 2023, then crashed by 97.79% to 0.0 in 2024, then plummeted by 106.92% to 0.0 in 2025.
- Its Asset Utilization Ratio was 0.0 in Q3 2025, compared to 0.0 in Q2 2025 and 0.02 in Q1 2025.